DrugPatentWatch Database Preview
Amneal Pharms Co Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for AMNEAL PHARMS CO, and what generic and branded alternatives to AMNEAL PHARMS CO drugs are available?
AMNEAL PHARMS CO has forty-two approved drugs.
There is one tentative approval on AMNEAL PHARMS CO drugs.
Summary for Amneal Pharms Co
| US Patents: | 0 |
| Tradenames: | 41 |
| Ingredients: | 41 |
| NDAs: | 42 |
Drugs and US Patents for Amneal Pharms Co
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharms Co | PREGABALIN | pregabalin | CAPSULE;ORAL | 209743-005 | Jul 19, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Amneal Pharms Co | PREGABALIN | pregabalin | CAPSULE;ORAL | 209743-003 | Jul 19, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Amneal Pharms Co | PREGABALIN | pregabalin | CAPSULE;ORAL | 209743-007 | Jul 19, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Amneal Pharms Co | DESIPRAMINE HYDROCHLORIDE | desipramine hydrochloride | TABLET;ORAL | 208105-004 | Mar 17, 2016 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for AMNEAL PHARMS CO drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 1 mg/mL, 50 mL vials | ➤ Subscribe | 2011-12-16 |
| ➤ Subscribe | Injection | 100 mg/mL, 2.5 mL vials | ➤ Subscribe | 2007-09-24 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
